Next generation sequencing of both primary and metastatic tumors from an estrogen-receptor-alpha-positive metastatic lobular BC case revealed that, from the 32 somatic non-synonymous coding mutations present in the metastatic sample, five were prevalent in the DNA of the primary tumor, including a somatic PALB2 mutation [146]. Here, PALB2 is linked to breast cancer.